Clinical and Radiological Features of Pneumocystis jirovecii Pneumonia in Children: A Case Series
Authors:
- Erica RicciERErica Ricci
- Claudia BartalucciCBClaudia Bartalucci
- Chiara RussoCRChiara Russo
- Marcello MarianiMMMarcello Mariani
- Carolina SaffiotiCSCarolina Saffioti
- Erika MassaccesiEMErika Massaccesi
- Filomena PierriFPFilomena Pierri
- Giacomo BriscaGBGiacomo Brisca
- Andrea MoscatelliAMAndrea Moscatelli
- Roberta CaorsiRCRoberta Caorsi
- Bianca BruzzoneBBBianca Bruzzone
- Maria Beatrice DamasioMDMaria Beatrice Damasio
Open Access
- 9 April 2024
- journal article
- case report
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (4) , 276
Abstract
Background: Pneumocytis jirovecii pneumonia (PJP) has high mortality rates in immunocompromised children, even though routine prophylaxis has decreased in incidence. The aim of this case series is to present the radiological and clinical pathway of PJP in a pediatric population. Description of Cases: All PJP cases in non-HIV/AIDS patients diagnosed at Istituto Giannina Gaslini Pediatric Hospital in Genoa (Italy) from January 2012 until October 2022 were retrospectively evaluated. Nine cases were identified (median age: 8.3 years), and of these, 6/9 underwent prophylaxis with trimethoprim/sulfamethoxazole (TMP/SMX; five once-a-week schedules and one three times-a-week schedule), while 3/9 did not receive this. PJP was diagnosed by real-time PCR for P. jirovecii-DNA in respiratory specimens in 7/9 cases and two consecutive positive detections of β-d-glucan (BDG) in the serum in 2/9 cases. Most patients (6/8) had a CT scan with features suggestive of PJP, while one patient did not undergo a scan. All patients were treated with TMP/SMX after a median time from symptoms onset of 3 days. In 7/9 cases, empirical TMP/SMX treatment was initiated after clinical suspicion and radiological evidence and later confirmed by microbiological data. Clinical improvement with the resolution of respiratory failure and 30-day survival included 100% of the study population. Discussion: Due to the difficulty in obtaining biopsy specimens, PJP diagnosis is usually considered probable in most cases. Moreover, the severity of the clinical presentation often leads physicians to start TMP/SMX treatment empirically. BDG proved to be a useful tool for diagnosis, and CT showed good accuracy in identifying typical patterns. In our center, single-day/week prophylaxis was ineffective in high-risk patients; the three-day/week schedule would, therefore, seem preferable and, in any case, should be started promptly in all patients who have an indication of pneumonia.Keywords
Funding Information
- Ministero della Salute—Ricerca Corrente 2023
This publication has 49 references indexed in Scilit:
- Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysisClinical Microbiology and Infection, 2022
- Pneumocystis jirovecii pneumonia at chest High-resolution Computed Tomography (HRCT) in non-HIV immunocompromised patients: Spectrum of findings and mimickersEuropean Journal of Radiology, 2019
- Fungal infections of the lung in childrenPediatric Radiology, 2016
- Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsCochrane Database of Systematic Reviews, 2014
- Single-Day Trimethoprim/Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia in Children with CancerThe Journal of Pediatrics, 2014
- HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patientsEuropean Journal of Radiology, 2012
- Clinical conditions associated with PCP in childrenPediatric Pulmonology, 2011
- Radiological Features of Pneumocystis jirovecii Pneumonia in Immunocompromised Patients with and Without AIDSLung, 2010
- Incidence of Opportunistic and Other Infections in HIV-Infected Children in the HAART EraJAMA, 2006
- Cotrimoxazole prophylaxis of Pneumocystis carinii infection during the treatment of childhood acute lymphoblastic leukemia--beware non compliance in older children and adolescents.Supportive Care in Cancer, 2001